Pursuant to provisions of Regulation 33 and 47(3) read with Schedule III of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 (‘Listing regulations’), JHS Svendgaard Laboratories has informed that the Board of Directors in its meeting held on 14th August, 2023 considered and approved the Un-Audited (Standalone and Consolidated) Financial results for the quarter ended June 30, 2023. Further the extract of the Financial Results, according to Regulation 47 of listing regulations, were published on August 15,2023, in Business Standard (English) and Business Standard (Hindi). Copies of the same are enclosed.
The above information is a part of company’s filings submitted to BSE.
